Copyright © 2006 The American Society of Human Genetics. All rights reserved.
The American Journal of Human Genetics, Volume 79, Issue 6, 1059-1070, 1 December 2006
doi:10.1086/510021
Article
James S. Friedmana, Bo Changc, Chitra Kannabirand, Christina Chakarovaf, Hardeep P. Singhd, Subhadra Jalalie, Norman L. Hawesc, Kari Branhama, Mohammad Othmana, Elena Filippovaa, Debra A. Thompsona, Andrew R. Websterf, g, Sten Andréassonh, Samuel G. Jacobsoni, Shomi S. Bhattacharyaf, John R. Heckenlively and Anand Swaroopb,
, 
a From the Department of Ophthalmology and Visual Sciences, W. K. Kellogg Eye Center, University of Michigan, Ann Arbor
b Department of Human Genetics, W. K. Kellogg Eye Center, University of Michigan, Ann Arbor
c the Jackson Laboratory, Bar Harbor, Maine
d Kallam Anji Reddy Molecular Genetics Laboratory, L. V. Prasad Eye Institute, Banjara Hills, Hyderaba, India
e Kannuri Santhamma Retina-Vitreous Services, L. V. Prasad Eye Institute, Banjara Hills, Hyderaba, India
f Department of Molecular Genetics, Institute of Ophthalmology, University College London, London
g Moorfield Eye Hospital, London
h Department of Ophthalmology, University Hospital of Lund, Lund, Sweden
i Department of Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia
Address for correspondence and reprints: Dr. Anand Swaroop, W. K. Kellogg Eye Center, University of Michigan, 1000 Wall Street, Ann Arbor, MI 48105Abstract
The rd3 mouse is one of the oldest identified models of early-onset retinal degeneration. Using the positional candidate approach, we have identified a C→T substitution in a novel gene, Rd3, that encodes an evolutionarily conserved protein of 195 amino acids. The rd3 mutation results in a predicted stop codon after residue 106. This change is observed in four rd3 lines derived from the original collected mice but not in the nine wild-type mouse strains that were examined. Rd3 is preferentially expressed in the retina and exhibits increasing expression through early postnatal development. In transiently transfected COS-1 cells, the RD3-fusion protein shows subnuclear localization adjacent to promyelocytic leukemia-gene-product bodies. The truncated mutant RD3 protein is detectable in COS-1 cells but appears to get degraded rapidly. To explore potential association of the human RD3 gene at chromosome 1q32 with retinopathies, we performed a mutation screen of 881 probands from North America, India, and Europe. In addition to several alterations of uncertain significance, we identified a homozygous alteration in the invariant G nucleotide of the RD3 exon 2 donor splice site in two siblings with Leber congenital amaurosis. This mutation is predicted to result in premature truncation of the RD3 protein, segregates with the disease, and is not detected in 121 ethnically matched control individuals. We suggest that the retinopathy-associated RD3 protein is part of subnuclear protein complexes involved in diverse processes, such as transcription and splicing.
| Different Functional Outcome of RetGC1 and RPE65 Gene Mutations in Leber Congenital Amaurosis The American Journal of Human Genetics, Volume 64, Issue 4, 1 April 1999, Pages 1225-1228 Isabelle Perrault, Jean-Michel Rozet, Imad Ghazi, Corinne Leowski, Michèle Bonnemaison, Sylvie Gerber, Dominique Ducroq, Annick Cabot, Eric Souied, Jean-Louis Dufier, Arnold Munnich and Josseline Kaplan | |
| Mutations in the ABCA4 (ABCR) Gene Are the Major Cause of Autosomal Recessive Cone-Rod Dystrophy The American Journal of Human Genetics, Volume 67, Issue 4, 1 October 2000, Pages 960-966 Alessandra Maugeri, B. Jeroen Klevering, Klaus Rohrschneider, Anita Blankenagel, Han G. Brunner, August F. Deutman, Carel B. Hoyng and Frans P.M. Cremers Abstract The photoreceptor cell–specific ATP-binding cassette transporter gene (ABCA4; previously denoted “ABCR”) is mutated in most patients with autosomal recessive (AR) Stargardt disease (STGD1) or fundus flavimaculatus (FFM). In addition, a few cases with AR retinitis pigmentosa (RP) and AR cone-rod dystrophy (CRD) have been found to have ABCA4 mutations. To evaluate the importance of the ABCA4 gene as a cause of AR CRD, we selected 5 patients with AR CRD and 15 patients with isolated CRD, all from Germany and The Netherlands . Single-strand conformation–polymorphism analysis and sequencing revealed 19 ABCA4 mutations in 13 (65%) of 20 patients. In six patients, mutations were identified in both ABCA4 alleles; in seven patients, mutations were detected in one allele. One complex ABCA4 allele (L541P;A1038V) was found exclusively in German patients with CRD; one patient carried this complex allele homozygously, and five others were compound heterozygous. These findings suggest that mutations in the ABCA4 gene are the major cause of AR CRD. A primary role of the ABCA4 gene in STGD1/FFM and AR CRD, together with the gene's involvement in an as-yet-unknown proportion of cases with AR RP, strengthens the idea that mutations in the ABCA4 gene could be the most frequent cause of inherited retinal dystrophy in humans. Abstract | | |
| Retinal Dehydrogenase 12 (RDH12) Mutations in Leber Congenital Amaurosis The American Journal of Human Genetics, Volume 75, Issue 4, 1 October 2004, Pages 639-646 Isabelle Perrault, Sylvain Hanein, Sylvie Gerber, Fabienne Barbet, Dominique Ducroq, Helene Dollfus, Christian Hamel, Jean-Louis Dufier, Arnold Munnich, Josseline Kaplan and Jean-Michel Rozet Abstract Leber congenital amaurosis (LCA), the most early-onset and severe form of all inherited retinal dystrophies, is responsible for congenital blindness. Ten LCA genes have been mapped, and seven of these have been identified. Because some of these genes are involved in the visual cycle, we regarded the retinal pigment epithelium and photoreceptor-specific retinal dehydrogenase (RDH) genes as candidate genes in LCA. Studying a series of 110 unrelated patients with LCA, we found mutations in the photoreceptor-specific RDH12 gene in a significant subset of patients (4.1%). Interestingly, all patients harboring RDH12 mutations had a severe yet progressive rod-cone dystrophy with severe macular atrophy but no or mild hyperopia. Abstract | | |